HUE053671T2 - Gliceril-tribenzoátot tartalmazó készítmény neurodegeneratív rendellenességben történõ alkalmazása - Google Patents
Gliceril-tribenzoátot tartalmazó készítmény neurodegeneratív rendellenességben történõ alkalmazásaInfo
- Publication number
- HUE053671T2 HUE053671T2 HUE15737329A HUE15737329A HUE053671T2 HU E053671 T2 HUE053671 T2 HU E053671T2 HU E15737329 A HUE15737329 A HU E15737329A HU E15737329 A HUE15737329 A HU E15737329A HU E053671 T2 HUE053671 T2 HU E053671T2
- Authority
- HU
- Hungary
- Prior art keywords
- composition
- neurodegenerative disorder
- glyceryl tribenzoate
- tribenzoate
- glyceryl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461928622P | 2014-01-17 | 2014-01-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE053671T2 true HUE053671T2 (hu) | 2021-07-28 |
Family
ID=53543490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE15737329A HUE053671T2 (hu) | 2014-01-17 | 2015-01-16 | Gliceril-tribenzoátot tartalmazó készítmény neurodegeneratív rendellenességben történõ alkalmazása |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9968582B2 (enExample) |
| EP (1) | EP3094616B1 (enExample) |
| JP (2) | JP6836905B2 (enExample) |
| CA (1) | CA2936548C (enExample) |
| CY (1) | CY1124115T1 (enExample) |
| DK (1) | DK3094616T3 (enExample) |
| ES (1) | ES2853974T3 (enExample) |
| HR (1) | HRP20210361T1 (enExample) |
| HU (1) | HUE053671T2 (enExample) |
| LT (1) | LT3094616T (enExample) |
| PL (1) | PL3094616T3 (enExample) |
| PT (1) | PT3094616T (enExample) |
| RS (1) | RS61611B1 (enExample) |
| SI (1) | SI3094616T1 (enExample) |
| SM (1) | SMT202100074T1 (enExample) |
| WO (1) | WO2015109215A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019070478A1 (en) * | 2017-10-06 | 2019-04-11 | Rush University Medical Center | USE OF A BENZOATE-CONTAINING COMPOSITION FOR TREATING GLYCINIC ENCEPHALOPATHY |
| MY197404A (en) * | 2017-11-22 | 2023-06-16 | Lin Chieh Hsin | Benzoic acid or a salt and derivative thereof for use in preventing or treating depression |
| EA202192199A1 (ru) * | 2019-02-25 | 2021-12-17 | Раш Юниверсити Медикал Сентер | Композиции, содержащие коричную кислоту, и способы их применения |
| JP2022541021A (ja) * | 2019-07-16 | 2022-09-21 | ラッシュ・ユニバーシティ・メディカル・センター | 神経変性障害を治療するためのベンゾエート含有組成物の使用 |
| CN116390761A (zh) * | 2020-10-28 | 2023-07-04 | 拉什大学医学中心 | 肉桂酸苄酯组合物在治疗甘氨酸脑病和尿素循环障碍中的应用 |
| CA3205005A1 (en) * | 2020-12-16 | 2022-06-23 | Rush University Medical Center | Administration of glycerol tribenzoate and glycerol phenylbutyrate for treatment of neurodegenerative and urea cycle disorders |
| EP4447952A4 (en) * | 2021-12-16 | 2025-11-19 | Us Gov Veterans Affairs | Benzoic acid salts for the treatment of injuries and disorders of the nervous system |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284647A (en) * | 1980-03-31 | 1981-08-18 | The Johns Hopkins University | Process for waste nitrogen removal |
| US20080171792A1 (en) * | 2006-12-28 | 2008-07-17 | Jobdevairakkam Christopher New | Use of highly concentrated formulations of 4-phenylbutyrate for treatment of certain disorders |
-
2015
- 2015-01-16 HU HUE15737329A patent/HUE053671T2/hu unknown
- 2015-01-16 JP JP2016565117A patent/JP6836905B2/ja active Active
- 2015-01-16 RS RS20210230A patent/RS61611B1/sr unknown
- 2015-01-16 US US15/110,702 patent/US9968582B2/en active Active
- 2015-01-16 SM SM20210074T patent/SMT202100074T1/it unknown
- 2015-01-16 HR HRP20210361TT patent/HRP20210361T1/hr unknown
- 2015-01-16 ES ES15737329T patent/ES2853974T3/es active Active
- 2015-01-16 PL PL15737329T patent/PL3094616T3/pl unknown
- 2015-01-16 DK DK15737329.1T patent/DK3094616T3/da active
- 2015-01-16 LT LTEP15737329.1T patent/LT3094616T/lt unknown
- 2015-01-16 SI SI201531511T patent/SI3094616T1/sl unknown
- 2015-01-16 EP EP15737329.1A patent/EP3094616B1/en active Active
- 2015-01-16 PT PT157373291T patent/PT3094616T/pt unknown
- 2015-01-16 CA CA2936548A patent/CA2936548C/en active Active
- 2015-01-16 WO PCT/US2015/011798 patent/WO2015109215A1/en not_active Ceased
-
2019
- 2019-10-18 JP JP2019191224A patent/JP2020037558A/ja active Pending
-
2021
- 2021-03-09 CY CY20211100204T patent/CY1124115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK3094616T3 (da) | 2021-02-15 |
| RS61611B1 (sr) | 2021-04-29 |
| JP6836905B2 (ja) | 2021-03-03 |
| US9968582B2 (en) | 2018-05-15 |
| SMT202100074T1 (it) | 2021-05-07 |
| EP3094616A1 (en) | 2016-11-23 |
| CA2936548C (en) | 2022-08-30 |
| SI3094616T1 (sl) | 2021-07-30 |
| JP2017505811A (ja) | 2017-02-23 |
| ES2853974T3 (es) | 2021-09-20 |
| JP2020037558A (ja) | 2020-03-12 |
| HRP20210361T1 (hr) | 2021-04-16 |
| US20160331714A1 (en) | 2016-11-17 |
| CA2936548A1 (en) | 2015-07-23 |
| CY1124115T1 (el) | 2022-05-27 |
| PL3094616T3 (pl) | 2021-05-31 |
| EP3094616B1 (en) | 2020-12-23 |
| EP3094616A4 (en) | 2017-08-23 |
| WO2015109215A1 (en) | 2015-07-23 |
| PT3094616T (pt) | 2021-03-03 |
| LT3094616T (lt) | 2021-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3513809A4 (en) | MEDICAL COMPOSITION | |
| BR112016013333A2 (pt) | composição para cuidado oral | |
| DK3030262T3 (da) | Kombineret farmaceutisk sammensætning | |
| DK3132034T3 (da) | Terapeutikum | |
| EP3002632A4 (en) | LIGHT-CURABLE ACRYLIC COMPOSITION | |
| EP2958994A4 (en) | Vaccine composition | |
| BR112016021011A2 (pt) | composição tópica e usos de um composto | |
| GB201408080D0 (en) | Skin care composition | |
| EP2961397A4 (en) | TRANSDERMAL FORMULATIONS | |
| EP3237013C0 (en) | TRANSDERMAL FORMULATIONS | |
| FI20146023A7 (fi) | Hammas- ja kielituki | |
| HUE053671T2 (hu) | Gliceril-tribenzoátot tartalmazó készítmény neurodegeneratív rendellenességben történõ alkalmazása | |
| IL250649A0 (en) | Topical composition containing ranpirnase | |
| PL3207149T3 (pl) | Kompozycja farmaceutyczna o zwiększonej stabilności | |
| CL2016001687A1 (es) | Colorante-polímero | |
| PL3145592T3 (pl) | Kompozycja do pielęgnacji skóry | |
| BR112017007645A2 (pt) | composições para tratar feridas | |
| DK3140050T3 (da) | Dosering med visning | |
| EP2994184C0 (en) | An unravelable catheter | |
| FR3021528B1 (fr) | Formulation cosmetique | |
| DK3089740T3 (da) | Farmaceutisk sammensætning | |
| FR3007291B1 (fr) | Composition cicatrisante et utlisation | |
| EP3441073A4 (en) | MEDICAL COMPOSITION | |
| FR3026994B1 (fr) | Glissiere non deformable en cas d'accident | |
| EP3134067C0 (en) | VETERINARY COMPOSITION |